Skip to main content
Equibles

Matthew W. Rosinack

Iovance Biotherapeutics, Inc. (IOVA)

Chief Accounting Officer

Iovance Biotherapeutics, Inc. (IOVA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Matthew W. Rosinack

Matthew W. Rosinack is recorded as Chief Accounting Officer at Iovance Biotherapeutics, Inc. (IOVA). Iovance Biotherapeutics, Inc. reported in an 8-K filed July 3, 2025 that Matthew W. Rosinack was appointed interim Principal Financial Officer and Principal Accounting Officer, effective June 30, 2025.

“Effective as of June 30, 2025, Matthew W. Rosinack, the Company's Senior Vice President, Finance, was appointed as the Company's interim Principal Financial Officer and Principal Accounting Officer.”
Iovance Biotherapeutics, Inc. Form 8-K, filed July 3, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Iovance Biotherapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.